influenza vaccine (FLU-v) / ConserV Biosci, Imutex, SEEK Group  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
influenza vaccine (FLU-v) / ConserV Biosci, Imutex
NCT03180801 / 2016-002134-74: Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

Completed
2b
153
Europe
adjuvanted FLU-v, adjuvanted placebo, Influenza challenge
PepTcell Limited, National Institute of Allergy and Infectious Diseases (NIAID)
Influenza
03/17
05/17
NCT02962908 / 2015-001932-38: A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine

Completed
2b
175
Europe
FLU-v, adjuvanted FLU-v, Saline, NaCl, Adjuvanted placebo
PepTcell Limited, Seventh Framework Programme, University of Groningen, University Medical Center Groningen, Robert Koch Institut, Norwegian Institute of Public Health
Influenza
07/17
07/17

Download Options